<- Go Home
Flerie AB (publ)
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Market Cap
SEK 1.7B
Volume
27.8K
Cash and Equivalents
SEK 305.7M
EBITDA
-SEK 40.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-SEK 25.7M
Profit Margin
458.93%
52 Week High
SEK 37.58
52 Week Low
SEK 19.05
Dividend
N/A
Price / Book Value
0.50
Price / Earnings
-2.04
Price / Tangible Book Value
0.50
Enterprise Value
SEK 1.4B
Enterprise Value / EBITDA
-35.19
Operating Income
-SEK 40.4M
Return on Equity
22.18%
Return on Assets
-0.67
Cash and Short Term Investments
SEK 305.7M
Debt
SEK 1.7M
Equity
SEK 3.4B
Revenue
-SEK 5.6M
Unlevered FCF
-SEK 27.0M
Sector
Pharmaceuticals
Category
N/A